SCHEMBL1624358

SCHEMBL1624358

O=c1[nH]c(CNS(=O)(=O)CCc2ccccc2)nc2ncncc12

nearest known ligand 0.46

Predicted protein targets (top 20)

geneUniProtsupporting neighboursconfidence
HCAR2 Q8TDS4 7/20 0.46
ALDH1A1 P00352 1/20 0.40
BRD4 O60885 1/20 0.40
PDE5A O76074 1/20 0.40
DAO P14920 3/20 0.37
MMP1 P03956 1/20 0.37
MMP7 P09237 1/20 0.37
MMP8 P22894 1/20 0.37
MMP12 P39900 1/20 0.37
MMP13 P45452 1/20 0.37
CYP17A1 P05093 1/20 0.37
TUBB4A P04350 1/20 0.36
TUBB P07437 1/20 0.36
TUBA3C P0DPH7 1/20 0.36
TUBA1B P68363 1/20 0.36
TUBA4A P68366 1/20 0.36
TUBB4B P68371 1/20 0.36
TUBB3 Q13509 1/20 0.36
TUBB2A Q13885 1/20 0.36
TUBB8 Q3ZCM7 1/20 0.36

Click a target to see other patent compounds predicted against it — the reverse direction, in place.

Similar compounds — the chemically nearest patent molecules

Nearest neighbours by Morgan-fingerprint cosine across the patent-compound collection, with each neighbour's top predicted target and the predicted targets it shares with this molecule.

Compoundsimilaritytop predictedshared targets
SCHEMBL1623229 0.79 HCAR2 (0.69) HCAR2PDE5ADAOTUBB4ATUBB
SCHEMBL1624581 0.79 HCAR2 (0.74) HCAR2ALDH1A1KMT2A
SCHEMBL1867573 0.73 HCAR2 (0.63) HCAR2
SCHEMBL1871317 0.71 HCAR2 (0.62) HCAR2
SCHEMBL1624709 0.70 TNKS (0.46) HCAR2PDE5ASMN1; SMN2
SCHEMBL1623385 0.68 PDE5A (0.44) HCAR2PDE5A
SCHEMBL1623347 0.67 PDE5A (0.50) HCAR2ALDH1A1PDE5AKMT2A
SCHEMBL1625617 0.65 HCAR2 (0.74) HCAR2PDE5A
SCHEMBL1624712 0.65 HCAR2 (0.74) HCAR2ALDH1A1PDE5ASMN1; SMN2
SCHEMBL15754219 0.64 L3MBTL1 (0.64) ALDH1A1MMP1MMP7MMP8MMP12

Similarity is cosine over the 2,048-bit Morgan fingerprint (≈ Tanimoto). Identical fingerprints score 1.00.

Patent provenance — the patents this molecule appears in, and who filed them

Claimed or disclosed in 1 patent. claimed = in the patent's claims; disclosed = body only.

PatentTitleAssigneePublishedPriorityFilingCountryStatus
US-7928106-B2 2-[2-(2,5-Difluoro-phenyl)-ethoxymethyl]-3H-pteridin-4-one; 2-2-(3-Fluoro-phenyl)-ethoxymethyl]-3H-pyrimido[4,5-d]pyrimidin-4-one; (5-Oxo-5,6-dihydro-pyrimido[4,5-c]pyridazin-7-ylmethyl)-carbamic acid benzyl ester, useful in treating diseases which are modulated by HM74A agonists e.g. dyslipidemia HOFFMANN-LA ROCHE INC. (US) 2011-04-19 US disclosed